Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Trends in mortality rates for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): experience of a single center in France between 1997 and 2017.

Bettuzzi T, Penso L, de Prost N, Hemery F, Hua C, Colin A, Mekontso-Dessap A, Fardet L, Chosidow O, Wolkenstein P, Sbidian E, Ingen-Housz-Oro S.

Br J Dermatol. 2019 Jul 19. doi: 10.1111/bjd.18360. [Epub ahead of print]

PMID:
31323695
2.

[Association between prescription of long-term systemic glucocorticoid therapy associated measures and prescriber's medical speciality].

Six M, Morin C, Fardet L.

Rev Med Interne. 2019 Jul;40(7):427-432. doi: 10.1016/j.revmed.2018.10.388. Epub 2019 Jan 22. French.

PMID:
30683427
3.

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Plaquevent M, Tétart F, Fardet L, Ingen-Housz-Oro S, Valeyrie-Allanore L, Bernard P, Hebert V, Roussel A, Avenel-Audran M, Chaby G, D'Incan M, Ferrier-Le-Bouedec MC, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Collet E, Labeille B, Morice C, Richard MA, Bourgault-Villada I, Litrowski N, Bara C, Mahe E, Prost-Squarcioni C, Alexandre M, Quereux G, Bernier C, Soria A, Thomas-Beaulieu D, Pauwels C, Dereure O, Benichou J, Joly P; French Investigators for Skin Adverse Reaction to Drugs; French Study Group on Autoimmune Bullous Skin Diseases.

J Invest Dermatol. 2019 Apr;139(4):835-841. doi: 10.1016/j.jid.2018.10.045. Epub 2018 Dec 10.

PMID:
30543900
4.

Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics.

Chaby G, Ingen-Housz-Oro S, De Prost N, Wolkenstein P, Chosidow O, Fardet L.

J Am Acad Dermatol. 2019 May;80(5):1453-1455. doi: 10.1016/j.jaad.2018.10.058. Epub 2018 Nov 2. No abstract available.

PMID:
30395917
5.

Response to: 'Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease' by Lee.

Fardet L, Petersen I, Nazareth I.

Ann Rheum Dis. 2018 Oct 18. pii: annrheumdis-2018-214515. doi: 10.1136/annrheumdis-2018-214515. [Epub ahead of print] No abstract available.

PMID:
30337423
6.

Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Proportion and determinants of underreporting to pharmacovigilance.

Chaby G, Lebrun-Vignes B, Haddad C, Hemery F, Ingen-Housz-Oro S, de Prost N, Wolkenstein P, Chosidow O, Fardet L.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1344-1346. doi: 10.1016/j.jaip.2018.09.028. Epub 2018 Oct 5. No abstract available.

PMID:
30292922
7.

Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease: a population-based cohort study.

Fardet L, Nazareth I, Petersen I.

Ann Rheum Dis. 2019 Feb;78(2):279-282. doi: 10.1136/annrheumdis-2018-214016. Epub 2018 Sep 5. No abstract available.

PMID:
30185414
8.

A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis.

Bigenwald C, Fardet L, Coppo P, Meignin V, Lazure T, Fabiani B, Kohn M, Oksenhendler E, Boutboul D, Uzzan M, Lambotte O, Galicier L.

Br J Haematol. 2018 Oct;183(1):68-75. doi: 10.1111/bjh.15506. Epub 2018 Jul 24.

PMID:
30043391
9.

Increased severity and epidermal alterations in persistent versus evanescent skin lesions in adult-onset Still disease.

Zuelgaray E, Battistella M, Sallé de Chou C, Vignon-Pennamen MD, Rybojad M, Petit A, Cordoliani F, Chasset F, Bachmeyer C, Fardet L, Fautrel B, Cacoub P, Lipsker D, Bagot M, Bouaziz JD.

J Am Acad Dermatol. 2018 Nov;79(5):969-971. doi: 10.1016/j.jaad.2018.05.020. Epub 2018 May 19. No abstract available.

PMID:
29787836
10.

[Treatment of severe cutaneous adverse drug reactions].

Ingen-Housz-Oro S, Duong TA, de Prost N, Colin A, Fardet L, Lebrun-Vignes B, Barbaud A, Chosidow O, Wolkenstein P; centre de référence des dermatoses bulleuses toxiques et toxidermies graves et le FISARD.

Ann Dermatol Venereol. 2018 Jun - Jul;145(6-7):454-464. doi: 10.1016/j.annder.2018.02.014. Epub 2018 Apr 13. French. No abstract available.

PMID:
29657073
11.

Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review.

Néel A, Wahbi A, Tessoulin B, Boileau J, Carpentier D, Decaux O, Fardet L, Geri G, Godmer P, Goujard C, Maisonneuve H, Mari A, Pouchot J, Ziza JM, Bretonnière C, Hamidou M.

Crit Care. 2018 Apr 11;22(1):88. doi: 10.1186/s13054-018-2012-2.

12.

Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins).

Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, Lebrun-Vignes B, Gueudry J, Bequignon E, Zaghbib K, Royer G, Colin A, Do-Pham G, Bodemer C, Ortonne N, Barbaud A, Fardet L, Chosidow O, Wolkenstein P; French National Reference Center for Toxic Bullous Dermatoses.

Orphanet J Rare Dis. 2018 Apr 10;13(1):56. doi: 10.1186/s13023-018-0793-7.

13.

Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'.

Dumas M, Hua C, Hotz C, Velter C, Duong TA, Maraffi T, Ortonne N, Hüe S, Fardet L, de Prost N, Wolkenstein P, Ingen-Housz-Oro S, Chosidow O.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e360-e361. doi: 10.1111/jdv.14935. Epub 2018 Mar 30. No abstract available.

PMID:
29524279
14.

Folate Supplementation During Methotrexate Therapy: A Population-based Retrospective Cohort Study.

Mazaud C, Fardet L.

Acta Derm Venereol. 2018 Apr 27;98(5):536-538. doi: 10.2340/00015555-2904. No abstract available.

15.

Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses.

Poizeau F, Gaudin O, Le Cleach L, Duong TA, Hua C, Hotz C, Ingen-Housz-Oro S, Sbidian E, Zehou O, Colin A, de Prost N, Lebrun-Vignes B, Chosidow O, Wolkenstein P, Fardet L.

J Invest Dermatol. 2018 Jun;138(6):1293-1300. doi: 10.1016/j.jid.2017.12.034. Epub 2018 Jan 31.

16.

Severe cutaneous adverse reactions due to inappropriate medication use.

Chaby G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, Milpied B, Sassolas B, Tetart F, Wolkenstein P, Chosidow O, Fardet L.

Br J Dermatol. 2018 Aug;179(2):329-336. doi: 10.1111/bjd.16365. Epub 2018 May 14.

PMID:
29352771
17.

Stevens-Johnson Syndrome During Pregnancy: Case Report of a Newborn Treated With the Culprit Drug.

Velter C, Hotz C, Ingen-Housz-Oro S, Wolkenstein P, Fardet L.

JAMA Dermatol. 2018 Feb 1;154(2):224-225. doi: 10.1001/jamadermatol.2017.4607. No abstract available.

PMID:
29261833
18.

[What's new in internal medicine?]

Fardet L.

Ann Dermatol Venereol. 2017 Dec;144 Suppl 4:IVS23-IVS28. doi: 10.1016/S0151-9638(17)31062-1. French.

PMID:
29249249
19.
20.

[Amiodarone-induced immune complex cutaneous vasculitis].

Ndiaye M, Lebrun-Vignes B, Ortonne N, Fardet L.

Ann Dermatol Venereol. 2017 Dec;144(12):788-792. doi: 10.1016/j.annder.2017.08.006. Epub 2017 Sep 19. French.

PMID:
28935425
21.

Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France.

Bénard-Laribière A, Pariente A, Pambrun E, Bégaud B, Fardet L, Noize P.

BMJ Open. 2017 Jul 31;7(7):e015905. doi: 10.1136/bmjopen-2017-015905.

22.

Agreement Between Self-reported Inflammatory Skin Disorders and Dermatologists' Diagnosis: A Cross-sectional Diagnostic Study.

Phan C, Ezzedine K, Lai C, Le Cleach L, Cogrel O, Fardet L, Wolkenstein P, Chosidow O, Beylot-Barry M, Sbidian E.

Acta Derm Venereol. 2017 Nov 15;97(10):1243-1244. doi: 10.2340/00015555-2749. No abstract available.

23.

Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.

Heidelberger V, Ingen-Housz-Oro S, Marquet A, Mahevas M, Bessis D, Bouillet L, Caux F, Chapelon-Abric C, Debarbieux S, Delaporte E, Duval-Modeste AB, Fain O, Joly P, Marchand-Adam S, Monfort JB, Noël N, Passeron T, Ruivard M, Sarrot-Reynauld F, Verrot D, Bouvry D, Fardet L, Chosidow O, Sève P, Valeyre D.

JAMA Dermatol. 2017 Jul 1;153(7):681-685. doi: 10.1001/jamadermatol.2017.1162. Erratum in: JAMA Dermatol. 2017 Aug 1;153(8):837.

24.

Association Between Long-term Quinine Exposure and All-Cause Mortality.

Fardet L, Nazareth I, Petersen I.

JAMA. 2017 May 9;317(18):1907-1909. doi: 10.1001/jama.2017.2332. No abstract available.

25.

Reporting of harm and safety results in randomized controlled trials published in 5 dermatology journals.

Haddad C, Sigha OB, Lebrun-Vignes B, Chosidow O, Fardet L.

J Am Acad Dermatol. 2017 Jul;77(1):98-104.e1. doi: 10.1016/j.jaad.2017.01.011. Epub 2017 Mar 14. Review.

PMID:
28314683
26.
27.

Use of topical glucocorticoids: a population-based cohort study.

El-Khoury M, Thay R, N'Diaye M, Fardet L.

J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1044-1047. doi: 10.1111/jdv.14149. Epub 2017 Feb 24.

PMID:
28150352
28.

Dermatological emergencies: evolution from 2008 to 2014 and perspectives.

Isnard C, Ingen-Housz-Oro S, Fardet L, Matteodo E, Duval S, Hemery F, Khellaf M, Duong TA, Chosidow O, Wolkenstein P.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):274-279. doi: 10.1111/jdv.13860. Epub 2016 Sep 29.

PMID:
27681584
29.

Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study.

Fardet L, Petersen I, Nazareth I.

PLoS Med. 2016 May 24;13(5):e1002024. doi: 10.1371/journal.pmed.1002024. eCollection 2016 May.

30.

[Henoch-Schönlein purpura-like vasculitis revealing HIV infection].

Isnard C, Fardet L, Duriez P, Morin C, Rivière S, Meynard JL, Surgers L.

Med Mal Infect. 2016 Sep;46(6):322-5. doi: 10.1016/j.medmal.2016.02.005. Epub 2016 Mar 30. French. No abstract available.

PMID:
27039067
31.

[Paroxysmal finger haematoma (Achenbach syndrome)].

Sigha B, Josselin L, Gatfosse M, Fardet L.

Ann Dermatol Venereol. 2016 Feb;143(2):130-3. doi: 10.1016/j.annder.2015.10.597. Epub 2016 Jan 7. French.

PMID:
26774542
32.

Clostridium difficile associated reactive arthritis: Case report and literature review.

Legendre P, Lalande V, Eckert C, Barbut F, Fardet L, Meynard JL, Surgers L.

Anaerobe. 2016 Apr;38:76-80. doi: 10.1016/j.anaerobe.2015.12.011. Epub 2015 Dec 30. Review.

PMID:
26743187
33.

Diversity and combinations of infectious agents in 38 adults with an infection-triggered reactive haemophagocytic syndrome: a multicenter study.

Lerolle N, Laanani M, Rivière S, Galicier L, Coppo P, Meynard JL, Molina JM, Azoulay E, Aumont C, Marzac C, Fardet L, Lambotte O.

Clin Microbiol Infect. 2016 Mar;22(3):268.e1-8. doi: 10.1016/j.cmi.2015.11.018. Epub 2015 Dec 12.

34.

Synthetic Glucocorticoids and Early Variations of Blood Pressure: A Population-Based Cohort Study.

Fardet L, Nazareth I, Petersen I.

J Clin Endocrinol Metab. 2015 Jul;100(7):2777-83. doi: 10.1210/jc.2015-1127. Epub 2015 May 15.

PMID:
25978108
35.

Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients.

Morin C, Fardet L.

Clin Rheumatol. 2015 Dec;34(12):2119-26. doi: 10.1007/s10067-015-2953-7. Epub 2015 May 9.

PMID:
25956956
36.

Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort study.

Fardet L, Petersen I, Nazareth I.

Medicine (Baltimore). 2015 Apr;94(15):e647. doi: 10.1097/MD.0000000000000647.

37.

Epstein-Barr virus viral load in human immunodeficiency virus-positive patients with reactive hemophagocytic syndrome.

Boisseau M, Lambotte O, Galicier L, Lerolle N, Marzac C, Aumont C, Coppo P, Fardet L.

Infect Dis (Lond). 2015 Jun;47(6):423-7. doi: 10.3109/00365548.2015.1007475. Epub 2015 Mar 6.

PMID:
25746607
38.

Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.

Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J; ANRS CO8 APROCO-COPILOTE Cohort Study Group.

J Antimicrob Chemother. 2015;70(6):1816-24. doi: 10.1093/jac/dkv036. Epub 2015 Mar 1.

PMID:
25733587
39.

[Cardiovascular pathologies and referrals for hospitalization by general practitioners: factors influencing the choice of a private or public hospital].

Bodin M, Blanchon T, Hanslik T, Turbelin C, Fardet L.

Ann Cardiol Angeiol (Paris). 2015 Apr;64(2):94-9. doi: 10.1016/j.ancard.2015.01.009. Epub 2015 Jan 20. French.

PMID:
25641085
40.

[Antibodies in dermatomyositis and other inflammatory myopathies: what the dermatologist must know].

Hüe S, Ingen-Housz-Oro S, Fardet L.

Ann Dermatol Venereol. 2015 Feb;142(2):149-54. doi: 10.1016/j.annder.2014.11.015. Epub 2015 Jan 9. French. No abstract available.

PMID:
25582572
41.

2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis.

Briot K, Cortet B, Roux C, Fardet L, Abitbol V, Bacchetta J, Buchon D, Debiais F, Guggenbuhl P, Laroche M, Legrand E, Lespessailles E, Marcelli C, Weryha G, Thomas T; Bone Section of the French Society for Rheumatology (SFR) and Osteoporosis Research and Information Group (GRIO).

Joint Bone Spine. 2014 Dec;81(6):493-501.

PMID:
25455041
42.

Reply: To PMID 24782338.

Fardet L, Lambotte O, Galicier L, Coppo P.

Arthritis Rheumatol. 2015 Feb;67(2):588. doi: 10.1002/art.38936. No abstract available.

43.

Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects.

Judd LL, Schettler PJ, Brown ES, Wolkowitz OM, Sternberg EM, Bender BG, Bulloch K, Cidlowski JA, de Kloet ER, Fardet L, Joëls M, Leung DY, McEwen BS, Roozendaal B, Van Rossum EF, Ahn J, Brown DW, Plitt A, Singh G.

Am J Psychiatry. 2014 Oct;171(10):1045-51. doi: 10.1176/appi.ajp.2014.13091264. Erratum in: Am J Psychiatry. 2014 Nov 1;171(11):1224.

PMID:
25272344
44.

Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.

Fardet L, Fève B.

Drugs. 2014 Oct;74(15):1731-45. doi: 10.1007/s40265-014-0282-9. Review.

PMID:
25204470
45.

Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide.

Arca M, Fardet L, Galicier L, Rivière S, Marzac C, Aumont C, Lambotte O, Coppo P.

Br J Haematol. 2015 Jan;168(1):63-8. doi: 10.1111/bjh.13102. Epub 2014 Aug 26.

PMID:
25157895
46.

Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.

Rivière S, Galicier L, Coppo P, Marzac C, Aumont C, Lambotte O, Fardet L.

Am J Med. 2014 Nov;127(11):1118-25. doi: 10.1016/j.amjmed.2014.04.034. Epub 2014 May 14.

PMID:
24835040
47.

Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.

Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G.

Arthritis Rheumatol. 2014 Sep;66(9):2613-20. doi: 10.1002/art.38690.

48.

A web-based delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients.

Hejblum G, Lambotte O, Galicier L, Coppo P, Marzac C, Aumont C, Fardet L.

PLoS One. 2014 Apr 7;9(4):e94024. doi: 10.1371/journal.pone.0094024. eCollection 2014.

49.

Primary-care physicians' patient referral patterns to private versus public hospitals for orthopaedic or trauma surgery-- French Sentinels® database, 1997-2011.

Rousseau AC, Blanchon T, Turbelin C, Cabane J, Hanslik T, Feron JM, Rousseau B, Fardet L.

Orthop Traumatol Surg Res. 2013 Oct;99(6):731-5. doi: 10.1016/j.otsr.2013.04.005. Epub 2013 Sep 9.

50.

[Glucocorticoid-induced adverse events in patients with giant cell arteritis or polymyalgia rheumatica].

Fardet L.

Rev Med Interne. 2013 Jul;34(7):438-43. doi: 10.1016/j.revmed.2013.02.031. Epub 2013 Jun 3. Review. French.

PMID:
23743479

Supplemental Content

Loading ...
Support Center